BD’s blood separation technology receives CE mark

Becton, Dickinson and Company (BD), a medical technology company, has obtained the CE mark in the UK and Europe for its next-generation blood separation technology

BD Vacutainer Barricor tube is a single-use, plastic evacuated tube used to collect, separate, transport and process venous blood specimens to obtain high-quality plasma for in vitro diagnostic use, according to BD.

BD said its Barricor tubes are optimised to deliver a high quality plasma sample by reducing cellular content (vs. plasma gel tubes), as a result of the mechanical separator remaining open throughout the centrifugation cycle.

According to the American Journal of Clinical Pathology, with 60% to 70% of the required information on a patient’s chart coming from laboratory test results, there is a high demand for rapid test turnaround time among clinicians.

Mike Fairbourn, vice president and general manager, UK and Ireland at BD, said:  “Laboratory technicians are forced to choose between a clean sample with serum and a fast sample with plasma.

“BD Barricor tubes eliminate this tradeoff, providing a cleaner and faster plasma sample than current methods.”

BD said its Vacutainer Barricor Plasma Blood Collection tube has separator technology that provides a cleaner plasma sample with less cellular contamination, meaning the sample is more stable and allows a longer window to conduct testing when compared to existing blood separation tubes.